NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
NASDAQ · Healthcare · Medical - Devices · US
$0.97
+12.96%Year over year
Reported trailing growth
- Revenue
- +50.8%
- EBITDA
- -56.8%
- EBIT
- -34.1%
- EPS
- —
- Free cash flow
- -75.2%
- Operating cash flow
- -77.3%
Forward estimates
Based on analyst estimates
- Revenue
- +33.4%
- EBITDA
- +31.2%
- EPS
- +30.0%
Three-year CAGR
- Revenue
- +313.5%
- EBITDA
- +74.6%
- EBIT
- +64.4%
- Net income
- +70.7%
- EPS
- +80.4%
- Free cash flow
- +73.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026